Skip to main content

Table 2 Extramedullary plasmacytoma cases of nasal and paranasal sinuses reported in the English language literature

From: Strategy for the treatment and follow-up of sinonasal solitary extramedullary plasmacytoma: a case series

Reference Pt Age/Sex Site Symptoms Treatment Recurrence Mts Follow-up
Ashraf et al. 2013 [7] 3 43/M Nasal cavity Nasal obstruction, epistaxis RT+surgery
Surgery+RT (44 Gy)
RT
No
No
No
No
No
No
1 year
1 year
3 years
Corvo et al. 2013 [13] 1 51/F Nasal cavity/maxillary sinus Nasal obstruction, epistaxis RT (48 Gy)+surgery No No 6 years
Verim et al. 2014 [10] 1 69/F Frontal sinus (4×3 cm) Chronic headache Surgery+RT (40 Gy) No No 18 months
D’Aguillo et al. 2014 [8] 175 55/
M:F of 2.3:1
M (69.4%)
F (30.6%)
Nasal cavity/septum (32.5%),
maxillary sinus (26.8%),
nasopharynx (18.6%),
ethmoid sinus (7.2%),
sphenoid sinus (6.7%),
paranasal sinus (6.2%),
frontal sinus (2.1%)
Nasal obstruction (29.8%),
epistaxis (24.2%),
facial swelling (9.9%),
facial pain (9.9%),
painless mass (6.8%),
change or loss of vision (6.2%),
nasal discharge (4.3%),
CN VI palsy (3.7%),
proptosis/ptosis (2.5%),
headache (2.5%)
RT (50.9%),
surgery+RT (21.7%),
surgery (14.3%),
CHT (1.7%),
RT+CHT (5.1%),
RT+Surgery+CHT (3.4%),
no therapy (2.9%)
16% No 39–60.9 months
  1. CHT chemotherapy, CN VI palsy sixth cranial nerve, F female, M male, Mts metastases, Pt patients, RT radiotherapy